Two Patients with Urachal Cancer with Multifocal Adenocarcinoma Recurrences in the Urothelium of the Prostatic and Penile Urethra

Collins, 2016, National incidence, management and survival of urachal carcinoma, Rare Tumors, 8, 97, 10.4081/rt.2016.6257 Sheldon, 1984, Malignant urachal lesions, J Urol, 131, 1, 10.1016/S0022-5347(17)50167-6 Ashley, 2006, Urachal carcinoma: clinicopathologic features and long-term outcomes of an aggressive malignancy, Cancer, 107, 712, 10.1002/cncr.22060 Szarvas, 2016, Clinical, prognostic, and therapeutic aspects of urachal carcinoma. A comprehensive review with meta-analysis of 1,010 cases, Urol Oncol, 34, 388, 10.1016/j.urolonc.2016.04.012 Gopalan, 2009, Urachal carcinoma: a clinicopathologic analysis of 24 cases with outcome correlation, Am J Surg Pathol, 33, 659, 10.1097/PAS.0b013e31819aa4ae Ching, 2011, Prostatic urethral recurrence of urachal adenocarcinoma, J Clin Oncol, 29, e736, 10.1200/JCO.2011.36.0222 Yasui, 1997, Urethral recurrence of an urachal carcinoma: a case report, Int J Urol, 4, 106, 10.1111/j.1442-2042.1997.tb00154.x Balcı, 2015, Patterns, risks and outcomes of urethral recurrence after radical cystectomy for urothelial cancer; over 20 year single center experience, Int J Surg, 13, 148, 10.1016/j.ijsu.2014.12.006 Stokkel LE, Stokkel MPM, Donswijk ML, et al. The diagnostic value of FDG-PET/CT for urachal cancer. Clin Genitourin Cancer In press. https://doi.org/10.1016/j.clgc.2021.03.002. Stokkel, 2020, Diagnostic laparoscopy and abdominal cytology reliably detect peritoneal metastases in patients with urachal adenocarcinoma, Ann Surg Oncol, 27, 2468, 10.1245/s10434-020-08206-1